Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Kadimastem Ltd. logo — A clinical stage biotech company using PLATFORM TECH for the...

Kadimastem Ltd.

A clinical stage biotech company using PLATFORM TECH for the Manufacturing of cells for ALS and Diabetes treatments

Founded 2009 Israel Israel 32 employees Grant Total: $51.65M Biotechnology, Health and Wellness

General Information

Company Name Kadimastem Ltd.
Founded Year 2009
Location Israel Israel +1
Founders / Decision Makers
Team member
Employees 32
Industries Biotechnology, Health and Wellness
Funding Stage Grant
Social

Get notified when Kadimastem Ltd. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Kadimastem Ltd.

Kadimastem Ltd. is a clinical stage biotech company that has been disrupting the industry since its establishment in 2009. The company's slogan "A clinical stage biotech company using PLATFORM TECH for the Manufacturing of cells for ALS and Diabetes treatments" embodies its commitment to leveraging cutting-edge TECHNOLOGY PLATFORM for the Development, Manufacturing, and Bio-Banking of functional human cells to provide OFF-THE-SHELF TREATMENT for multiple indications, with a focus on addressing ALS and Type 1 Diabetes. Kadimastem, listed as TASE:KDST, is headquartered in Israel. The company's recent milestone includes receiving a grant investment from the BIRD Foundation on 19 January 2023. This investment signifies external validation and support for Kadimastem's innovative approach and potential in the biotechnology space. With a focus on pioneering treatments for debilitating diseases, Kadimastem is poised to make significant strides in the biotech sector, positioning itself as a promising opportunity for venture capital consideration.

Taxonomy: Biotech, Stem Cell Therapy, Regenerative Medicine, Neurodegenerative Disorders, Cell Manufacturing, Drug Screening, High Content Screening, Cell-based Therapeutics, GMP Facilities, Type 1 Diabetes, ALS Treatment, Clinical Trials, Diabetes Cure, Israel, Bio-banking

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
19 Jan 2023
Post-IPO Equity •••••• 1
Investor
25 Nov 2021
Post-IPO Equity •••••• 4 •••• •••• 26 Oct 2021
Post-IPO Equity •••••• 1
Investor
02 Oct 2018
Post-IPO Equity •••••• - 01 Dec 2017

View All 8 Funding Rounds

Kadimastem Ltd. Alternatives & Competitors

Kadimastem Ltd. vs
Fluicell
Fluicell Sweden

Making tissue therapeutics possible to defeat serious disease

Post Ipo Equity
16 employees
Biotechnology, Health Care
Compare Kadimastem Ltd. vs Fluicell
Kadimastem Ltd. vs
BetaLife
BetaLife Singapore

A stem cell therapy company that is developing regenerative medicine for diabetes.

6 employees
Kadimastem Ltd. vs
Orgenesis Inc.
Orgenesis Inc. United States

Unlocking the Potential of Cell and Gene Therapy for All (NASDAQ: ORGS)

Grant
65 employees
Biotechnology, Health Care
Compare Kadimastem Ltd. vs Orgenesis Inc.
Also compare with: Kadimastem Ltd. vs DiogenX DiogenX

FAQ About Kadimastem Ltd.

A clinical stage biotech company using PLATFORM TECH for the Manufacturing of cells for ALS and Diabetes treatments
Kadimastem Ltd. was founded in 2009.
Kadimastem Ltd. is headquartered in Israel.
Kadimastem Ltd. operates in the following industries: Biotechnology, Health and Wellness.
Kadimastem Ltd. has approximately 32 employees.
Kadimastem Ltd. has completed 8 funding rounds, raising a total of $51.65M. The latest funding stage is Grant.
Top alternatives and competitors to Kadimastem Ltd. include Fluicell, BetaLife, Orgenesis Inc., DiogenX, inscreenex GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Kadimastem Ltd. and Fluicell are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Kadimastem Ltd. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy